glp-1 receptor agonist list agonists Indications for GLP-1/GIP RA Summary
Description
Assessing the plot, the excess hazard was initially negative (significantly so), but temporarily increased towards zero after around four to six years of exposure, after which it declined once more
Sehgal P, Lichtenstein GR, Khanna T, et al
The appetite suppression in mice receiving allulose was greater, weight loss was greater, and the regain of lost weight after stopping supplementation was slower with allulose than with semaglutide
Diabetes 38: 338-342, 1989
Both compound classes activate the human GLP-1R and have been engineered to have action profiles compatible with once-daily or once-weekly administration
In the T2D trial, WL was lower than in the obesity trial however the trial duration was shorter (36 weeks) [46]
